INDP Indaptus Therapeutics: Forvard P/S multiplikatori
Indaptus Therapeutics (INDP) kompaniyasining strategik vektori makroshoklarga chidamli saratonni davolash usullarini yaratishga qaratilgan. Biznesning forward P/S ko'rsatkichi ushbu yo'ldagi progressni namoyish etmoqda, bunda yangi darajani belgilaydi. Terapiyada nobud etilgan bakteriyalardan foydalanishning murakkabligi to'siq bo'lib xizmat qilmoqda; biroq, tajribali rahbariyat pul oqimini samarali boshqarib, joriy klinik sinovlarning barqarorligini ta'minlamoqda.
Indaptus Corp (INDP) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning kapitalga nisbati Indaptus Therapeutics|INDP - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Indaptus Therapeutics|INDP - Kompaniyaning jamlangan qarzdorligi|Qarzning balans qiymatiga nisbati Indaptus Corp|INDP - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli majburiyatlari Indaptus Therapeutics|Tezkor likvidlik indaptusrx.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
INDP - Sof moliyaviy natija|Kelajakdagi foyda Indaptus Therapeutics|INDP - Kompaniya qiymatining sof foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Indaptus|INDP - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Indaptus Corp|INDP - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|Bir aksiya uchun sof foyda (EPS TTM) Indaptus Therapeutics|INDP - So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi indaptusrx.com|INDP - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun foyda o'sishi prognozi Indaptus Therapeutics
- sotuvlar va tushum ko'rsatkichlari:
Fundamental baholash:Indaptus Therapeutics, Inc. (INDP)
Indaptus Therapeutics (INDP) immunoterapiyasining samaradorligi global dori vositalarini ro'yxatga olishni sekinlashtiradigan va daromadlar o'sishini cheklaydigan geosiyosiy to'siqlar bilan cheklangan. Bozor kapitalizatsiyasining prognoz qilingan savdo hajmi bilan nisbati aktivlarni monetizatsiya qilishga oid bozor kutuvlarini real vaqt rejimida baholash imkonini beradi, kelajakdagi P/S ko'rsatkichi esa tartibga soluvchi o'zgarishlar va to'xtab qolgan klinik sinovlar fonida kompaniyaning haddan tashqari yuqori baholanganligining ko'rsatkichi bo'lib xizmat qiladi.
Raqobatdosh kompaniyalar
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati ADMA Corp ADMA|Protagonist Therapeutics (PTGX) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati IMVT|KNSA (Kiniksa) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati GRFS (Grifols SA)|Forvard P/S multiplikatori ADPT|Forvard P/S multiplikatori Celldex Corp (CLDX)|Narxning prognoz qilingan daromadga nisbati Aurinia Pharmaceuticals AUPH|BCRX (biocryst.com) - Kelajakdagi narxning daromadga nisbati|VERA: Forvard narx/daromad multiplikatori|Dianthus Therapeutics Inc - Narxning kutilayotgan daromadga nisbati|PHVS (Pharvaris Corp) - Forvard narx/daromad multiplikatori|AbCellera Corp (ABCL) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Tourmaline Bio, Inc.|precigen.com (PGEN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Sotuvga nisbatan forvard narx|Upstream Bio Corp - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati ZBIO (Zenas Corp)|Immunome, Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx GOSS (gossamerbio.com)|KALV: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Septerna, Inc. (SEPN)|Narxning prognoz qilingan daromadga nisbati Pieris Pharmaceuticals Inc|SVRA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori RIGL|Forvard P/S multiplikatori anaptysbio.com (ANAB)|Narxning prognoz qilingan daromadga nisbati Astria Therapeutics, Inc. ATXS|ENGN (enGene Holdings Inc) - Kelajakdagi narxning daromadga nisbati|RAPT Therapeutics, Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aerovate Therapeutics Inc|ACRS (Aclaris Therapeutics) - Forvard narx/daromad multiplikatori|kyvernatx.com (KYTX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori TLSA|CABA (Cabaletta Bio Inc.) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori VTYX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Theratechnologies, Inc|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc)|ELDN - Forvard narx/daromad multiplikatori|AGEN - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Climb Bio Inc. CLYM|ZURA: Forvard P/S multiplikatori|ATYR - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Adagene Inc|Kapitalizatsiyaning prognoz qilingan daromadga nisbati IMA (Ikena Oncology, Inc.)|Forvard P/S multiplikatori STTK|equilliumbio.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Connect Biopharma Holdings Limited CNTB|IMUX (Immunic Therapeutics) - Kelajakdagi narxning daromadga nisbati|ATRA - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati IFRX|XFOR: Forvard P/S multiplikatori|Adicet Bio, Inc. - Sotuvga nisbatan forvard narx|CELU (Celularity Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori INmune Bio Corporation|Narxning prognoz qilingan daromadga nisbati Barinthus Biotherapeutics (BRNS)|KZR (kezarlifesciences.com) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati SAB Biotherapeutics, Inc. SABS|AKTX - Forvard narx/daromad multiplikatori|Enlivex Therapeutics, Ltd. - Forvard P/S multiplikatori|QTTB - Forvard P/S multiplikatori|GOVX (GeoVax Labs, Inc.) - Forvard narx/daromad multiplikatori|edesabiotech.com - Sotuvga nisbatan forvard narx|IBIO (iBio) - Forvard P/S multiplikatori|Carisma Tx (CARM) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati XTL Biopharmaceuticals, Ltd. (XTLB)|Forvard narx/daromad multiplikatori boltbio.com BOLT|Narxning prognoz qilingan daromadga nisbati HCW Biologics HCWB|APVO - Forvard narx/daromad multiplikatori|AIM: Forvard narx/daromad multiplikatori|ADTX - Forvard P/S multiplikatori|GRI Bio Corp (GRI) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati XRTX|HIND (Vyome Holdings Inc) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati revbiosciences.com REVB|Forvard P/S multiplikatori SCNI|Kapitalizatsiyaning kutilayotgan sotuvga nisbati calcimedica.com|Narxning prognoz qilingan daromadga nisbati Affimed N.V. AFMD|ALLK: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|HOOKIPA - Forvard P/S multiplikatori|IGMS (IGM Biosciences, Inc.) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ITOS: Forvard P/S multiplikatori|Ocean Biomedical Inc (OCEA) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Third Harmonic Bio Inc - Kelajakdagi narxning daromadga nisbati
